ProBio’s CRDMO facility for antibody discovery, is a critical hub in our global network, purpose-built to support end-to-end antibody discovery from target to preclinical candidate, integrated with CMC and clinical development to help accelerate the path from discovery to IND.
Learn more at: https://www.probiocdmo.com/discovery